Partner Headlines - AMGN

  1. Short Sellers Come Back To Biotech Stocks

    Benzinga
  2. Making Money With Charles Payne: 02/25/15

    FoxBusiness
  3. Evercore ISI Technical Analysis: The 'Single Best Idea'

    Benzinga
  4. A Look At Dan Loeb's Diversified 13F

    Benzinga
  5. Simons-Founded Renaissance Technologies Buys Apple, Closes Facebook, ...

    Benzinga
  6. Short Sellers Retreat From Biotech Stocks

    Benzinga
  7. FDA Advisory Committee To Review Amgen's Talimogene Laherparepvec

    Benzinga
  8. Dan Loeb Offers Mea Culpa For 'Mediocre' Returns

    Benzinga
  9. Dan Loeb Fourth Quarter Investor Letter

    GuruFocus
  10. Regeneron Q4 Sales, 2015 Outlook Upbeat On Eylea

    IBD
  11. Generic-Drug Makers Soar, And It's Easy To See Why

    IBD
  12. Pfizer Buying Hospira To Inject Growth Into Generics

    IBD
  13. Nuveen's Bob Doll Runs Several Top Funds

    IBD
  14. Biotech Stocks Down Despite Strong Amgen Quarter

    IBD
  15. Credit Suisse Sees Solid Q4 For Amgen

    Benzinga
  16. Amgen Q4 earnings top views

    IBD
  17. Drug Firms Report Good Q4, But Outlook Cloudy

    IBD
  18. Making Money With Charles Payne: 01/27/15

    FoxBusiness
  19. Amgen Beats Q4 Expectations

    Benzinga
  20. Stocks Weaken Late; Apple Jumps After Hours

    IBD
  21. Earnings Scheduled For January 27, 2015

    Benzinga
  22. 5 Big Biotech Earnings Releases To Watch This Week

    Benzinga
  23. Can CAR-T Therapy Live Up To The Biotech IPO Hype?

    IBD
  24. New Guru Jana Partners' Newest Stock Buys

    GuruFocus
  25. Express Scripts Eyes New Price War: Anti-PCSK9 Drugs

    IBD
  26. Cholesterol Drug Costs Eyed

    IBD
  27. Amgen's Decline May Be Linked To Comments Of Express Script's ...

    Benzinga
  28. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  29. Regeneron rises on drug data

    IBD
  30. Crude Awakening As Energy Squeezes Overall Q4 Profit

    IBD
  31. Regeneron Jumps On Favorable Cholesterol Drug Report

    IBD
  32. Drugs May Be Blockbusters

    IBD
  33. Weekly Review Shows Five Industries Gain In December

    IBD
  34. 5 Potential Blockbuster Drugs Set To Launch In 2015

    IBD
  35. Pharmaceutical Companies Amgen and Kite Partner for Cancer Therapy

    GuruFocus
  36. Kite Pharma Gets Stock Price Increase Post Amgen Deal

    IBD
  37. UPDATE: Barclays Initiates Coverage On Amgen

    Benzinga
  38. Amgen, Kite Reach Cell Deal

    IBD
  39. Hot Biotech Stocks: Isis, Kite Jump On Big Deals

    IBD
  40. Morgan Stanley Issues Wave Of Pharma & Medical Device Upgrades, ...

    Benzinga
  41. Kite Pharma Up On Amgen Cancer Parternship

    IBD
  42. Stocks Drop 1% In Rising Volume; Visa Falls 1%

    IBD
  43. Morning Market Losers

    Benzinga
  44. Monday #PreMarket Movers: Conatus Pharmaceuticals, Brainstorm ...

    Benzinga
  45. Amgen and Kite Pharma Announce Strategic Cancer Immunotherapy ...

    Benzinga
  46. Nasdaq, Russell 2000 Join New-High Party; GoPro Up Again

    IBD
  47. Tesla Motors Up On Battery News; Stocks At Record

    IBD
  48. Biotech Stocks Take A Beating, But Find Support

    IBD
  49. Are There Any Winners Left In The Biotech Space?

    Benzinga
  50. Indexes Turn Mixed On Data; Celgene Dives

    IBD
  51. Express Scripts Picks AbbVie HCV Drugs Over Gilead

    IBD
  52. Stocks Struggle To Hold Gains; Alaska Air, Spirit Up

    IBD
  53. Meet 5 Big Tech Stocks Expected To See Profits Surge

    IBD
  54. Amgen Just Crashed 50% In Premarket, Here's How It Looked

    Benzinga
  55. Druckenmiller Adds Healthcare Stocks to Portfolio

    GuruFocus
  56. Meet 5 Top Biotech Stocks Holding Up In Shaky Market

    IBD
  57. How Can Drugmakers Handle New Pricing Pressures?

    IBD
  58. Gilead Sciences Bucks Trend In Biotech Short Interest

    Benzinga
  59. 3 Biotech ETFs Rally On Merger News

    Benzinga
  60. New Trial Initiated Evaluating Amgen's Talimogene Laherparepvec ...

    Benzinga
  61. Hot Drugmakers Build More Labs, Grab Space In Boston

    IBD
  62. Large-Blend Funds Take The Lead For Year-To-Date Total Returns

    Benzinga
  63. A Look At 3 Overbought ETFs

    Benzinga
  64. Big CEOs Are Less Upbeat, But Plan To Hire More

    IBD
  65. Endonovo Therapeutics Receives Final Commissioned Report Recommendations ...

    GuruFocus
  66. Meet 5 Top Drug Stocks That Are Bolting Past Market

    IBD
  67. AMGEN

    IBD
  68. #PreMarket Primer: Tuesday, November 25: Violent Protests In ...

    Benzinga
  69. Dividend Aristocrats In Focus Part 45: AbbVie

    GuruFocus
  70. Amgen Announces Termination Of All Amgen-Sponsored Clinical Studies ...

    Benzinga
  71. #PreMarket Primer: Wednesday, November 19: Burst Of Cold Creates ...

    Benzinga
  72. Merck Drug Works: Vytorin Study Proves Successful

    IBD
  73. Events for the Week of Nov. 17-21, 2014

    Benzinga
  74. Amgen Shares Consolidating Ahead Of More Gains?

    Benzinga
  75. UPDATE: Deutsche Bank Reiterates On Amgen On Potential Of New ...

    Benzinga
  76. Amgen And AstraZeneca Announce Positive Results From Second Pivotal ...

    Benzinga
  77. Big Cap 20 Stuffed With Medical Names

    IBD
  78. Markets Mostly Lower As Americans Head To Vote, Oil Continues ...

    Benzinga
  79. AbbVie Beats Q3 Earnings Estimates, Raises Guidance

    IBD
  80. Ebola Vaccine Contenders

    Benzinga
  81. Stocks Trim Losses After Fed Report; Solarwinds Soars

    IBD
  82. UPDATE: Nomura Upgrades Amgen

    Benzinga
  83. Amgen resists pressure to split

    IBD
  84. Amgen: Stronger Drug Portfolio with Acquisition

    GuruFocus
  85. Amgen Refuses To Split, But Plans Hearten Investors

    IBD
  86. Amgen At All-Time High, Deutsche Bank Ups Price Target

    Benzinga
  87. Stocks Extend Gains As Alibaba, Tesla Rally

    IBD
  88. Stocks Launch In Climbing Mood; Amgen, Spirit Airlines Climbing

    IBD
  89. Amgen Rallies 3% After Announcing Growth And Capital Plans

    Benzinga
  90. Four Biotechs Lead Health Care Stocks In Big Cap 20

    IBD
  91. Amgen Q3 Earnings Beat Estimates; Guidance Mixed

    IBD
  92. Amgen Earnings Clear Views

    IBD
  93. Amgen Beats Q3 Earnings Estimates

    Benzinga
  94. Twitter Off, Amgen, Buffalo Wild Wings Up After Hours

    IBD
  95. Dow, Nasdaq Battle Near Flat Line; Energy Weighs On S&P 500

    IBD
  96. #PreMarket Primer: Monday, October 27: ECB Stress Tests In-Line ...

    Benzinga
  97. Earnings Scheduled For October 27, 2014

    Benzinga
  98. Keep an Eye on These 7 Stocks for October 27, 2014

    Benzinga
  99. Stocks Put End To Four-Week Slide

    IBD
  100. Fast Money Picks For October 23

    Benzinga
Trading Center